Journal
EMBO REPORTS
Volume 6, Issue 9, Pages 826-830Publisher
WILEY
DOI: 10.1038/sj.embor.7400505
Keywords
adjuvant; autoimmunity; immunity; membrane repair; synaptotagmin VII
Categories
Funding
- NIAID NIH HHS [R37-AI34867, R37 AI034867] Funding Source: Medline
- NIGMS NIH HHS [R01 GM064625, R01-GM064625] Funding Source: Medline
Ask authors/readers for more resources
Antigens are able to elicit productive immune responses only when second signals are provided by adjuvant molecules. It is well established that exogenously acquired, pathogen-associated molecular patterns fulfil this adjuvant role when recognized by specific receptors on antigen-presenting cells. Recent evidence points to the existence of another class of adjuvant, which is apparently released from injured cells. Such endogenous adjuvants, referred to as 'danger' signals, could alert the immune system to situations that cause cell damage, but not necessarily those that involve infections. Endogenous adjuvants provide a good explanation for immune responses generated against tumours and autologous tissues, but it has been difficult to explain how a constant activation of the immune system is avoided, considering the frequency at which cells are injured in vivo. Here, we suggest that the efficiency with which cells reseal wounds in their plasma membrane might be an important factor in the balance between tolerance and autoimmunity. Recent observations in synaptotagmin-VII-deficient mice suggest that defective membrane repair could lead to autoimmunity in tissues that are more susceptible to mechanical injury.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available